IMERYS (EPA:NK) - Number of outstanding shares and voting rights as of February 29, 2020
Transparency directive : regulatory news
05/03/2020 07:35
Click here to download pdf version
INFORMATION
5 March 2020
Number of outstanding shares and voting rights as of 29 February 2020 published
pursuant to the provisions of article L. 233-8-II of the French Code de
Commerce and articles 221-1 et seq. and 223-16 of the AMF's General
Regulations
29 February 2020
Total number of outstanding shares 79,343,115
Total number of theoretical voting rights
determined on all the shares making up the
share capital, including those without
voting rights (*) 126,703,685
Total number of net voting rights 126,257,768
(*) Treasury shares
The world leader in mineral-based specialty solutions for industry with EUR4.4
billion in revenue and 16,300 employees in 2019. Imerys delivers high
value-added, functional solutions to a great number of sectors, from processing
industries to consumer goods. The Group draws on its understanding of
applications, technological knowledge and expertise in material science to
deliver solutions by beneficiating its mineral resources, synthetic minerals
and formulations. Imerys' solutions contribute essential properties to
customers' products and their performance, including heat resistance, hardness,
conductivity, opacity, durability, purity, lightness, filtration, absorption
and water repellency. Imerys is determined to develop responsibly, in
particular by fostering the emergence of environmentally-friendly products and
processes.
More comprehensive information about Imerys may be obtained from its website
(www.imerys.com) under Regulated Information, particularly in its Registration
Document filed with Autorité des marchés financiers on March 20, 2019
under number D.19-0175 (also available from the Autorité des marchés
financiers website, www.amf-france.org). Imerys draws the attention of
investors to chapter 4, "Risk Factors and Internal Control" of its Registration
Document.
Disclaimer: This document contains projections and other forward-looking
statements. Investors should be aware that such projections and forward-looking
statements are subject to various risks and uncertainties (many of which are
diffcult to predict and generally beyond the control of Imerys) that could
cause actual results and developments to differ materially from those expressed
or implied
Investor Relations
Vincent Gouley + 33 (0)1 49 55 64 69
finance@imerys.com
Press Contact
Claire Garnier +33 (0)1 4955 6427